Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsDivislaboratories

    Jump to

    • Buy Divis Laboratories; target of Rs 1250: Motilal Oswal

      Motilal Oswal is bullish on Divis Laboratories and has recommended buy rating on the stock with a target of Rs 1250 in its May 21, 2013 research report.

    • Buy Divis Laboratories; target Rs 1276: Nirmal Bang

      Nirmal Bang is bullish on Divis Laboratories (DLL) and has recommended buy rating on the stock with a target price of Rs 1276 in its March 22, 2013 research report.

    • Buy Divis Labs; target of Rs 1450: Motilal Oswal

      Motilal Oswal is bullish on Divis Labs and has recommended buy rating on the stock with a target of Rs 1450 in its February 4, 2013 research report.

    • Accumulate Divis Labs; target of Rs 1109: PLilladher

      Prabhudas Lilladher is bullish on Divis Labs and has recommended accumulate rating on the stock with a target of Rs 1109 in its February 4, 2013 research report.

    • Accumulate Divis Labs; target of Rs 1233: Dolat Capital

      Dolat Capital is bullish on Divis Labs and has recommended accumulate rating on the stock with a target of Rs 1233 in its February 4, 2013 research report.

    • Buy Divis Labs; target of Rs 1218: Firstcall Research

      Firstcall Research is bullish on Divis Laboratories and has recommended buy rating on the stock with a target of Rs 1218 in its December 21, 2012 research report.

    • Dolat Capital handpicks 18 stocks for investment

      Dolat Capital has come out with its report on 20 stocks. The research firm recommends buy ratings for 18 stocks and Sell ratings for 2 stocks.

    • Accumulate Divis Laboratories; target Rs 1296: P Lilladher

      Prabhudas Lilladher is bullish on Divis Laboratories and has recommended accumulate rating on the stock with a target price of Rs 1296 in its November 05, 2012 research report.

    • Accumulate Divis Laboratories; target Rs 1296: PLilladher

      Prabhudas Lilladher is bullish on Divis Laboratories and has recommended accumulate rating on the stock with a target of Rs 1296 in its November 5, 2012 research report.

    • Buy Divis Laboratories; target Rs 1250: Emkay

      Emkay Global Financial Services is bullish on Divis Laboratories and has recommended buy rating on the stock with a target price of Rs 1250 in its November 5, 2012 research report.

    • Buy Divis Laboratories; target of Rs 1230: Motilal Oswal

      Motilal Oswal is bullish on Divis Laboratories and has recommended buy rating on the stock with a target of Rs 1230 in its November 5, 2012 research report.

    • Accumulate Divis Labs; target of Rs 1280: Dolat Capital

      Dolat Capital is bullish on Divis Laboratories and has recommended accumulate rating on the stock with a target of Rs 1280 in its August 7, 2012 research report.

    • Buy Divis Labs; target of Rs 1250: Motilal Oswal

      Motilal Oswal is bullish on Divis Labs and has recommended buy rating on the stock with a target of Rs 1250 in its August 6, 2012 research report.

    • Buy Berger Paints, Divis Lab, Cadila Health, CEBBCO: Emkay

      Emkay Global Financial Services has come out with its report on various stocks. The research firm recommends buying Berger Paints, Divis Lab, Cadila Health and CEBBCO.

    • 15 stocks to buy this earning season: Emkay

      Emkay Global Financial Services has come out with its report on various stocks like Cadila Healthcare, HDFC Bank, ICICI Bank etc. The research firm recommends buying this stock.

    • Buy Divi's Labs; target of Rs 1287: Ventura

      Ventura is bullish on Divis Laboratories and has recommended buy rating on the stock with a target of Rs 1287 in its June 22, 2012 research report.

    • Buy Divis Laboratories; target Rs 927: Emkay

      Emkay Global Financial Services is bullish on Divis Laboratories and has recommended buy rating on the stock with a target price of Rs 927 in its January 30, 2012 research report.

    • Unicon recommends 8 stocks for long term investment

      Unicon Investment has come out with its report on leveraged companies. The broking firm has identified have identified 8 companies with strong growth trajectories and debt to equity ratio less than or equal to one

    • Buy Divis Labs; target of Rs 927: Motilal Oswal

      Motilal Oswal is bullish on Divis Labs and has recommended buy rating on the stock with a target of Rs 927 in its August 8, 2011 research report.

    • Sharekhan buys Glenmark Pharma, CESC; sells Lupin

      Sharekhan has come out with its report on various stocks.

    • Buy Divi's Labs; Hold Madras Cem, Tata Global: Sharekhan

      Sharekhan has come out with its report on various stocks.

    • Buy Divis Labs; target of Rs 927: Emkay

      Emkay Global Financial Services is bullish on Divis Labs and has recommended buy rating on the stock with a target of Rs 927 in its August 8, 2011 research report.

    • Buy Divis Laboratories; target of Rs 927: Emkay

      Emkay Global Financial Services is bullish on Divis Laboratories and has recommended buy rating on the stock with a target of Rs 927 in its May 20, 2011 research report.

    • Buy Divis Labs; target of Rs 889: KRChoksey

      KRChoksey is bullish on Divis Labs and has recommended buy rating on the stock with a target of Rs 889 in its May 18, 2011 research report.

    • Buy Divis Laboratories; target of Rs 833: Emkay

      Emkay Global Financial Services is bullish on Divis Laboratories and has recommended buy rating on the stock with a target of Rs 833 in its March 30, 2011 research report.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347